当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Anna Thorbiörnson, Tomislav Vladic and Ylva Vladic Stjernholm*
Objective: To compare the efficacy and safety with oral prostaglandin in solution versus vaginal prostaglandin gel for labour induction. Design: A retrospective observational study. Methods: Data from obstetric records in a university hospital in Sweden 2012-2013. Results: In all women, oral prostaglandin resulted in vaginal birth <24 in 66% compared to 80% with vaginal treatment (p < 0.001), and caesarean section in 19% versus 32% (p = 0.02). In primiparous women, oral prostaglandin lead to vaginal birth <24 hours in 54% compared to 71% (p = 0.01), and caesarean section in 25% versus 41% (p = 0.03). In women with an unripe cervix, oral prostaglandin lead to vaginal birth < 24 hours in 66% compared to 79% (p = 0.01), and caesarean section in 21% versus 33% (p = 0.04). Despite a longer induction to vaginal delivery interval with oral prostaglandin, the rates of obstetric bleeding, chorioamnionitis, uterine hyperstimulation and neonatal asphyxia were not increased. Conclusions: Oral prostaglandin was less effective than vaginal prostaglandin in achieving vaginal birth < 24 hours. However, oral prostaglandin was safer, since it resulted in fewer caesarean sections in all women, primiparous women and women with an unripe cervix.